The ability to turn a gene off only in a specific cell type is essential to modern life science. Thanks to the Cre-Controlled CRISPR it has just became simpler. The new method developed by researchers from the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden with support from ... more
Dr. Torsten Tonn
Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus
Torsten Tonn is Professor for Transfusion Medicine at the Medical Faculty Carl Gustav Carus, Technical University in Dresden. He is also CEO of the German Red Cross Blood Donation Service North/East. Prior to this position, he served as head of the cell and gene therapy unit of the Institute for Transfusion Medicine in Frankfurt/M. His interest is the improvement of quality and safety of cell based products and the translation of advanced cell therapies into the clinic.